🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 21 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/09/2010 | 5,95 | 5,95 | 5,84 | 5,91 | +0,64% | 1,89% | 72.456 |
| 29/09/2010 | 5,88 | 5,91 | 5,84 | 5,88 | +0,00% | 1,27% | 38.365 |
| 28/09/2010 | 5,88 | 5,95 | 5,80 | 5,88 | +0,00% | 2,55% | 46.247 |
| 27/09/2010 | 5,95 | 5,95 | 5,80 | 5,88 | -1,88% | 2,52% | 63.158 |
| 24/09/2010 | 5,99 | 6,03 | 5,95 | 5,99 | +0,00% | 1,25% | 92.066 |
| 23/09/2010 | 5,88 | 5,99 | 5,84 | 5,99 | +1,27% | 2,55% | 45.766 |
| 22/09/2010 | 5,99 | 6,21 | 5,91 | 5,91 | -3,66% | 5,00% | 37.403 |
| 21/09/2010 | 5,95 | 6,25 | 5,91 | 6,14 | +2,50% | 5,66% | 71.387 |
| 20/09/2010 | 5,84 | 6,03 | 5,84 | 5,99 | +2,56% | 3,20% | 73.043 |
| 17/09/2010 | 5,99 | 5,99 | 5,84 | 5,84 | -0,64% | 2,50% | 131.286 |
| 16/09/2010 | 5,91 | 5,95 | 5,73 | 5,88 | -0,63% | 3,80% | 32.915 |
| 15/09/2010 | 5,95 | 5,99 | 5,88 | 5,91 | -1,25% | 1,89% | 32.060 |
| 14/09/2010 | 6,21 | 6,25 | 5,91 | 5,99 | -3,61% | 5,42% | 79.669 |
| 13/09/2010 | 6,03 | 6,25 | 5,99 | 6,21 | +3,75% | 4,35% | 110.714 |
| 10/09/2010 | 5,76 | 5,99 | 5,76 | 5,99 | +3,90% | 3,90% | 58.590 |
| 09/09/2010 | 5,61 | 5,76 | 5,54 | 5,76 | +3,36% | 4,00% | 68.849 |
| 08/09/2010 | 5,65 | 5,76 | 5,50 | 5,58 | -0,67% | 4,64% | 47.342 |
| 07/09/2010 | 5,69 | 5,73 | 5,58 | 5,61 | -1,96% | 2,63% | 32.060 |
| 03/09/2010 | 5,76 | 5,76 | 5,61 | 5,73 | +0,00% | 2,60% | 46.460 |
| 02/09/2010 | 5,65 | 5,76 | 5,50 | 5,73 | +2,00% | 4,64% | 32.381 |
| 01/09/2010 | 5,58 | 5,61 | 5,46 | 5,61 | +3,45% | 2,68% | 78.627 |
| 31/08/2010 | 5,43 | 5,69 | 5,43 | 5,43 | +0,00% | 4,83% | 55.116 |
| 30/08/2010 | 5,76 | 5,80 | 5,43 | 5,43 | -6,45% | 6,49% | 62.250 |
| 27/08/2010 | 5,58 | 5,84 | 5,50 | 5,80 | +5,44% | 6,04% | 75.341 |
| 26/08/2010 | 5,65 | 5,73 | 5,50 | 5,50 | -2,65% | 3,97% | 63.212 |
| 25/08/2010 | 5,58 | 5,69 | 5,50 | 5,65 | +0,67% | 3,35% | 61.929 |
| 24/08/2010 | 5,54 | 5,65 | 5,46 | 5,61 | +0,00% | 3,38% | 66.364 |
| 23/08/2010 | 5,73 | 5,84 | 5,61 | 5,61 | -1,31% | 3,92% | 52.231 |
| 20/08/2010 | 5,73 | 5,84 | 5,69 | 5,69 | -1,30% | 2,62% | 76.570 |
| 19/08/2010 | 6,21 | 6,21 | 5,73 | 5,76 | -7,78% | 7,83% | 96.260 |